• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基底神经节内谷氨酸能系统与单胺能系统之间的相互作用——对精神分裂症和帕金森病的影响。

Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease.

作者信息

Carlsson M, Carlsson A

机构信息

Department of Pharmacology, University of Göteborg, Sweden.

出版信息

Trends Neurosci. 1990 Jul;13(7):272-6. doi: 10.1016/0166-2236(90)90108-m.

DOI:10.1016/0166-2236(90)90108-m
PMID:1695402
Abstract

Recent animal experiments suggest that dopamine plays a less crucial role than formerly supposed in the regulation of psychomotor functions. This is illustrated by the finding that even in the almost complete absence of brain dopamine, a pronounced behavioural activation is produced in mice following suppression of glutamatergic neurotransmission. This paper discusses the possibility that a deficient activity within the corticostriatal glutamatergic/aspartergic pathway may be an important pathophysiological component in schizophrenia, and that glutamatergic agonists may be beneficial in the treatment of this disease. In addition, it is suggested that glutamatergic antagonists may be valuable supplements in the treatment of Parkinson's disease.

摘要

最近的动物实验表明,多巴胺在精神运动功能调节中所起的作用比以前认为的要小。这一点体现在以下发现中:即使在大脑多巴胺几乎完全缺失的情况下,抑制谷氨酸能神经传递后,小鼠仍会产生明显的行为激活。本文讨论了皮质纹状体谷氨酸能/天冬氨酸能通路内活性不足可能是精神分裂症重要病理生理组成部分的可能性,以及谷氨酸能激动剂可能对该病治疗有益的观点。此外,有人提出谷氨酸能拮抗剂可能是帕金森病治疗中有价值的补充药物。

相似文献

1
Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease.基底神经节内谷氨酸能系统与单胺能系统之间的相互作用——对精神分裂症和帕金森病的影响。
Trends Neurosci. 1990 Jul;13(7):272-6. doi: 10.1016/0166-2236(90)90108-m.
2
Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems.通过给予NMDA拮抗剂干扰谷氨酸能神经传递,可揭示其他递质系统的运动刺激潜能。
Pharmacol Biochem Behav. 1990 May;36(1):45-50. doi: 10.1016/0091-3057(90)90123-y.
3
Schizophrenia: a subcortical neurotransmitter imbalance syndrome?精神分裂症:一种皮质下神经递质失衡综合征?
Schizophr Bull. 1990;16(3):425-32. doi: 10.1093/schbul/16.3.425.
4
Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease.基底神经节中的谷氨酸-多巴胺相互作用:与帕金森病的关系。
J Neural Transm Gen Sect. 1993;91(2-3):255-69. doi: 10.1007/BF01245235.
5
Behavioural pharmacology of glutamate in the basal ganglia.
J Neural Transm Suppl. 1992;38:65-89.
6
Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophrenia.大脑中的谷氨酸能-多巴胺能平衡。其在运动障碍和精神分裂症中的重要性。
Arzneimittelforschung. 1992 Feb;42(2A):265-8.
7
Excitatory amino acids and Parkinson's disease.
Trends Neurosci. 1990 Feb;13(2):46-7. doi: 10.1016/0166-2236(90)90066-j.
8
5-HT1A receptor-dependent control of nigrostriatal dopamine neurotransmission in the pharmacotherapy of Parkinson's disease and schizophrenia.5-羟色胺1A受体依赖性对帕金森病和精神分裂症药物治疗中黑质纹状体多巴胺神经传递的控制
Behav Pharmacol. 2015 Feb;26(1-2):45-58. doi: 10.1097/FBP.0000000000000123.
9
MK-801 powerfully protects against N-methyl aspartate neurotoxicity.
Eur J Pharmacol. 1987 Sep 23;141(3):357-61. doi: 10.1016/0014-2999(87)90552-8.
10
Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia.
J Cereb Blood Flow Metab. 1988 Oct;8(5):757-62. doi: 10.1038/jcbfm.1988.124.

引用本文的文献

1
Contributions of Basal Ganglia Circuits to Perception, Attention, and Consciousness.基底神经节回路对感知、注意和意识的贡献。
J Cogn Neurosci. 2024 Jul 1;36(8):1620-1642. doi: 10.1162/jocn_a_02177.
2
Increasing striatal dopamine release through repeated bouts of theta burst transcranial magnetic stimulation of the left dorsolateral prefrontal cortex. A 18F-desmethoxyfallypride positron emission tomography study.通过对左侧背外侧前额叶皮层进行重复的theta爆发式经颅磁刺激来增加纹状体多巴胺释放。一项18F-去甲氧基氟哌啶正电子发射断层扫描研究。
Front Neurosci. 2024 Jan 18;17:1295151. doi: 10.3389/fnins.2023.1295151. eCollection 2023.
3
Transport and inhibition mechanisms of human VMAT2.
人 VMAT2 的转运和抑制机制。
Nature. 2024 Feb;626(7998):427-434. doi: 10.1038/s41586-023-06926-4. Epub 2023 Dec 11.
4
Dopamine D2 receptor antagonist modulates rTMS-induced pain experiences and corticospinal excitability dependent on stimulation targets.多巴胺D2受体拮抗剂根据刺激靶点调节重复经颅磁刺激诱发的疼痛体验和皮质脊髓兴奋性。
Int J Clin Health Psychol. 2024 Jan-Mar;24(1):100413. doi: 10.1016/j.ijchp.2023.100413. Epub 2023 Oct 27.
5
GRIN2A (NR2A): a gene contributing to glutamatergic involvement in schizophrenia.GRIN2A(NR2A):一个与精神分裂症谷氨酸能参与有关的基因。
Mol Psychiatry. 2023 Sep;28(9):3568-3572. doi: 10.1038/s41380-023-02265-y. Epub 2023 Sep 22.
6
The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia.精神分裂症中强迫症症状的神经生物学基础,治疗抵抗性精神分裂症的转化问题。
Biomolecules. 2023 Aug 5;13(8):1220. doi: 10.3390/biom13081220.
7
Abscisic acid ameliorates motor disabilities in 6-OHDA-induced mice model of Parkinson's disease.脱落酸可改善6-羟基多巴胺诱导的帕金森病小鼠模型的运动功能障碍。
Heliyon. 2023 Jul 20;9(8):e18473. doi: 10.1016/j.heliyon.2023.e18473. eCollection 2023 Aug.
8
A challenge to the dopamine orthodoxy in schizophrenia?对精神分裂症中多巴胺正统观念的挑战?
Aust N Z J Psychiatry. 2023 Sep;57(9):1198-1199. doi: 10.1177/00048674231177958. Epub 2023 Jun 2.
9
Integrative Roles of Dopamine Pathway and Calcium Channels Reveal a Link between Schizophrenia and Opioid Use Disorder.多巴胺通路与钙通道的综合作用揭示了精神分裂症与阿片类药物使用障碍之间的联系。
Int J Mol Sci. 2023 Feb 17;24(4):4088. doi: 10.3390/ijms24044088.
10
Preconditioning prefrontal connectivity using transcranial direct current stimulation and transcranial magnetic stimulation.使用经颅直流电刺激和经颅磁刺激对前额叶连接进行预处理。
Front Hum Neurosci. 2022 Aug 11;16:929917. doi: 10.3389/fnhum.2022.929917. eCollection 2022.